Research model supports strategies that increase PSA screening interval and age-specific thresholds for biopsy
Using higher thresholds for biopsy referral for older men and screening men with initially low prostate-specific antigen (PSA) levels less frequently seem to reduce harms of screening while preserving lives, a study found.
5 Feb 2013
Patients expect it and internists won't let it go. But does the evidence support the need for the periodic health exam? Experts weigh in on the value of regularly seeing a patient on a preventive basis.
1 Jan 2010
A provisional clinical opinion from the American Society of Clinical Oncology (ASCO) recommends against prostate-specific antigen screening for men with a life expectancy of 10 years or less.
24 Jul 2012
An obscure nutrient is now being hailed as a link to prevention of diseases as disparate as diabetes, schizophrenia, cancer, strokes and heart attacks. Experts square off on how much vitamin D can be associated with illnesses, the proper amount that people should get, and how they can get it.
1 Nov 2009
In last week's ACP InternistWeekly, the first sentence of the item on reimbursement cuts and prostate drugs should have read “Medicare reimbursement cuts were associated with reduced use of androgen-deprivation therapy for prostate cancer, particularly among men for whom the benefits of such therapy were unclear.” The item has been updated.
16 Nov 2010
This column reviews details on recent recalls, warnings, and approvals.
1 Oct 2019
A new analysis quantified the effects of prostate-specific antigen (PSA) screening on men's quality of life.
21 Aug 2012
Alcohol is associated with so many benefits and harms that it's hard to know where to start talking to patients about using it. One place might be alcohol misuse and abuse. Teach patients where they fall on the continuum of drinking behavior.
1 Jan 2013
Medicare expands tobacco cessation coverage
31 Aug 2010
A summary of approvals, recalls and a record number of deaths and serious injuries reported.
1 Jan 2009